COVID-19: Omicron Transmissibility, Severity, and Vaccine Effectiveness
Transmissibility, disease severity, and vaccine effectiveness are different with the SARS-CoV-2 omicron variant compared with the ancestral virus and prior variants. Hear expert faculty discuss what we know about omicron.
Decera Clinical Education Infectious Disease Podcast · Sharon R. Lewin AO FRACP PhD FAHMS
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses what is known about the SARS-CoV-2 omicron variant, including:
Transmissibility and infectiousness
- Immune evasion
Disease severity
- Risks of hospitalization and death
Vaccine effectiveness
- 2- vs 3-dose vaccine effectiveness
- T-cell response
Presenter:
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
Melbourne, Australia
Review the downloadable slidesets at:
https://bit.ly/32tp2BT
Link to full program:
https://bit.ly/3Ix8uZg
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.